洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR1800017905】COMPARISON OF EFFECTIVENESS OF MEDIAN NERVE NEURODYNAMIC MOBILIZATION VERSUS CARPAL BONE MOBILIZATION ON PAIN, SYMPTOM SEVERITY AND FUNCTIONAL STATUS IN CARPAL TUNNEL SYNDROME

基本信息
登记号

ChiCTR1800017905

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2018-08-20

临床申请受理号

/

靶点

/

适应症

Carpal Tunnel Syndrome

试验通俗题目

COMPARISON OF EFFECTIVENESS OF MEDIAN NERVE NEURODYNAMIC MOBILIZATION VERSUS CARPAL BONE MOBILIZATION ON PAIN, SYMPTOM SEVERITY AND FUNCTIONAL STATUS IN CARPAL TUNNEL SYNDROME

试验专业题目

COMPARISON OF EFFECTIVENESS OF MEDIAN NERVE NEURODYNAMIC MOBILIZATION VERSUS CARPAL BONE MOBILIZATION ON PAIN, SYMPTOM SEVERITY AND FUNCTIONAL STATUS IN CARPAL TUNNEL SYNDROME

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

54000

联系人通讯地址
临床试验信息
试验目的

To determine the effectiveness of median nerve mobilization vs. carpal bone mobilization in reducing pain & symptom severity and improving functional status in subjects with carpal tunnel syndrome

试验分类
试验类型

随机平行对照

试验分期

Ⅰ期

随机化

The patients will be asked to choose a token from the a box on which group of patient will be mentioned. Box will be filled with equal number of tokens for both groups to ensure equal sample size. None of the patients will be aware of the subgroup they will have

盲法

/

试验项目经费来源

Self Financed

试验范围

/

目标入组人数

30

实际入组人数

/

第一例入组时间

2018-08-01

试验终止时间

2018-11-30

是否属于一致性

/

入选标准

1. Age 25-55 years. 2. Both male and female patients diagnosed with CTS; 3. Patients with positive phalen's test, positive tinel's test and positive upper limb tension test for median nerve; 4. Patient's having median nerve latencies above 4ms.;

排除标准

1. Any red flags (tumor, fracture, metabolic diseases, rheumatoid arthritis, osteoporosis,HTN, prolonged history of steroid use, etc); 2. Patients with double crush syndrome, cervical or thoracic origin of symptoms, scaphoid instability, shoulder injuries, recent fractures and crush injuries, hypermobile joints, pregnancy and women undergoing hormone replacement therapy; 3. Evidence of central nervous system involvement; 4. Patients who requested to leave the study and history of other treatments including local corticosteroid and using of physical modalities and physiotherapy injection and splint in 3 months ago; 5. Any sensory and/or motor deficit in either ulnar or radial nerve.;

研究者信息
研究负责人姓名
试验机构

Riphah International University, Pakistan

研究负责人电话
研究负责人邮箱
研究负责人邮编

5400

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品